{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:37:53Z","timestamp":1788435473230,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>MicroRNAs (miRNAs) target genes involved in the hyperproliferation of keratinocytes or immune dysfunction of psoriasis. This study prospectively determined the involvement of miR-183-3p in the pathogenesis of psoriasis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Differentially expressed miR-183-3p between psoriatic lesional and non-lesional skin were determined by quantitative RT-PCR and in situ hybridization (ISH). CCK8 and wound healing assays were performed to assess cell viability and migration of human keratinocyte cell line (HaCaT). The target of miR-183-3p was validated by luciferase activity assay.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Lower miR-183-3p expression was observed in psoriatic lesional skin compared to psoriatic non-lesional skin. MiR-183-3p over-expression inhibited the viability and migration of HaCaT cells, while inhibition of miR-183-3p promoted the viability and migration of HaCaT cells. Moreover, miR-183-3p could bind to the 3\u2032 UTR of GAB1 (growth factor receptor binding 2-associated binding protein 1) and decrease the mRNA and protein expression of GAB1 in HaCaT cells. In addition, higher GAB1 expression was observed in psoriatic lesional skin than psoriatic non-lesional skin.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>MiR-183-3p exhibited inhibition property in the proliferation and migration of HaCaT cells via down-regulation of GAB1, suggesting the potential therapeutic strategy for psoriasis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s41065-020-00138-w","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T15:03:51Z","timestamp":1594393431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["miR-183-3p suppresses proliferation and migration of keratinocyte in psoriasis by inhibiting GAB1"],"prefix":"10.1186","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5144-6382","authenticated-orcid":false,"given":"Ting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"138_CR1","first-page":"324","volume":"39","author":"LL GR","year":"2018","unstructured":"GR LL, Du Thanh A. Squamous cell carcinoma antigen elevation in cervical cancer follow-up: the forest hiding the tree. Eur J Gynaecol Oncol. 2018;39:324\u20136.","journal-title":"Eur J Gynaecol Oncol"},{"key":"138_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12016-007-0039-2","volume":"33","author":"BJ Nickoloff","year":"2007","unstructured":"Nickoloff BJ, Qin JZ, Nestle FO. Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol. 2007;33:45\u201356.","journal-title":"Clin Rev Allergy Immunol"},{"key":"138_CR3","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1159\/000430158","volume":"36","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Tu C, Zhang D, Zheng Y, Peng Z, Feng Y, et al. Wnt\/beta-catenin and Wnt5a\/ca pathways regulate proliferation and apoptosis of keratinocytes in psoriasis lesions. Cell Physiol Biochem. 2015;36:1890\u2013902.","journal-title":"Cell Physiol Biochem"},{"key":"138_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.clindermatol.2007.08.013","volume":"25","author":"C Albanesi","year":"2007","unstructured":"Albanesi C, De Pita O, Girolomoni G. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol. 2007;25:581\u20138.","journal-title":"Clin Dermatol"},{"key":"138_CR5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1261\/rna.1534709","volume":"15","author":"G Sotiropoulou","year":"2009","unstructured":"Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z. Emerging roles of MicroRNAs as molecular switches in the integrated circuit of the cancer cell. RNA (New York, NY). 2009;15:1443\u201361.","journal-title":"RNA (New York, NY)"},{"key":"138_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/exd.13249","volume":"26","author":"Q Liu","year":"2017","unstructured":"Liu Q, Wu DH, Han L, Deng JW, Zhou L, He R, et al. Roles of microRNAs in psoriasis: immunological functions and potential biomarkers. Exp Dermatol. 2017;26:359\u201367.","journal-title":"Exp Dermatol"},{"key":"138_CR7","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","volume":"2","author":"E Sonkoly","year":"2007","unstructured":"Sonkoly E, Wei T, Janson PCJ, S\u00e4\u00e4f A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One. 2007;2:e610.","journal-title":"PLoS One"},{"key":"138_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/jid.2011.55","volume":"131","author":"N Xu","year":"2011","unstructured":"Xu N, Brodin P, Wei T, Meisgen F, Eidsmo L, Nagy N, et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol. 2011;131:1521\u20139.","journal-title":"J Invest Dermatol"},{"key":"138_CR9","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.bbadis.2017.08.014","volume":"1863","author":"S Chowdhari","year":"2017","unstructured":"Chowdhari S, Sardana K, Saini N. miR-4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin\/integrin alpha9 signaling. Biochimica Et Biophysica Acta Mol Basis Dis. 2017;1863:3142\u201352.","journal-title":"Biochimica Et Biophysica Acta Mol Basis Dis"},{"key":"138_CR10","doi-asserted-by":"publisher","first-page":"144136","DOI":"10.1016\/j.gene.2019.144136","volume":"726","author":"S Ouyang","year":"2020","unstructured":"Ouyang S, Chen W, Zeng G, Lei C, Tian G, Zhu M, et al. MicroRNA-183-3p up-regulated by vagus nerve stimulation mitigates chronic systolic heart failure via the reduction of BNIP3L-mediated autophagy. Gene. 2020;726:144136.","journal-title":"Gene."},{"key":"138_CR11","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s12094-014-1183-9","volume":"16","author":"F Xu","year":"2014","unstructured":"Xu F, Zhang H, Su Y, Kong J, Yu H, Qian B. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers. Clin Transl Oncol. 2014;16:980\u20135.","journal-title":"Clin Transl Oncol"},{"key":"138_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s11064-018-2529-4","volume":"43","author":"D-N Shi","year":"2018","unstructured":"Shi D-N, Yuan Y-T, Ye D, Kang L-M, Wen J, Chen H-P. MiR-183-5p alleviates chronic constriction injury-induced neuropathic pain through inhibition of TREK-1. Neurochem Res. 2018;43:1143\u20139.","journal-title":"Neurochem Res"},{"key":"138_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jdermsci.2010.03.004","volume":"58","author":"JR Zibert","year":"2010","unstructured":"Zibert JR, L\u00f8vendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci. 2010;58:177\u201385.","journal-title":"J Dermatol Sci"},{"key":"138_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000495291","volume":"235","author":"F Benhadou","year":"2019","unstructured":"Benhadou F, Mintoff D, Del Marmol V. Psoriasis: keratinocytes or immune cells - which is the trigger? Dermatology. 2019;235:91\u2013100.","journal-title":"Dermatology."},{"key":"138_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jid.2019.01.026","volume":"139","author":"N Garzorz-Stark","year":"2019","unstructured":"Garzorz-Stark N, Eyerich K. Psoriasis pathogenesis: keratinocytes are Back in the spotlight. J Investig Dermatol. 2019;139:995\u20136.","journal-title":"J Investig Dermatol"},{"key":"138_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.1996.tb15660.x","volume":"135","author":"JP Ortonne","year":"1996","unstructured":"Ortonne JP. Aetiology and pathogenesis of psoriasis. Br J Dermatol. 1996;135:1\u20135.","journal-title":"Br J Dermatol"},{"key":"138_CR17","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/bjd.15185","volume":"176","author":"S Korkmaz","year":"2017","unstructured":"Korkmaz S, Korkmaz H. Effect of alterations in apoptotic pathway on development of metabolic syndrome in patients with psoriasis vulgaris. Br J Dermatol. 2017;176:1549\u201357.","journal-title":"Br J Dermatol"},{"key":"138_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/CM9.0000000000000140","volume":"132","author":"X-L Niu","year":"2019","unstructured":"Niu X-L, Huang Y, Gao Y-L, Sun Y-Z, Han Y, Chen H-D, et al. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis. Chin Med J. 2019;132:690\u20138.","journal-title":"Chin Med J"},{"key":"138_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1600-0625.2011.01288.x","volume":"20","author":"IV Litvinov","year":"2011","unstructured":"Litvinov IV, Bizet AA, Binamer Y, Jones DA, Sasseville D, Philip A. CD109 release from the cell surface in human keratinocytes regulates TGF-\u03b2 receptor expression, TGF-\u03b2 signalling and STAT3 activation: relevance to psoriasis. Exp Dermatol. 2011;20:627\u201332.","journal-title":"Exp Dermatol"},{"key":"138_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jaci.2015.01.033","volume":"136","author":"S Mashiko","year":"2015","unstructured":"Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol. 2015;136:351\u20139 e1.","journal-title":"J Allergy Clin Immunol"},{"key":"138_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.biopha.2017.05.005","volume":"91","author":"H Shen","year":"2017","unstructured":"Shen H, Zeng B, Wang C, Tang X, Wang H, Liu W, et al. MiR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1. Biomed Pharmacother. 2017;91:803\u201311.","journal-title":"Biomed Pharmacother"},{"key":"138_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.canlet.2018.11.035","volume":"443","author":"K Ichiyama","year":"2019","unstructured":"Ichiyama K, Dong C. The role of miR-183 cluster in immunity. Cancer Lett. 2019;443:108\u201314.","journal-title":"Cancer Lett"},{"key":"138_CR23","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.immuni.2016.05.015","volume":"44","author":"K Ichiyama","year":"2016","unstructured":"Ichiyama K, Gonzalez-Martin A, Kim BS, Jin HY, Jin W, Xu W, et al. The MicroRNA-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 expression. Immunity. 2016;44:1284\u201398.","journal-title":"Immunity."},{"key":"138_CR24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1089\/dna.2019.4642","volume":"38","author":"Y Li","year":"2019","unstructured":"Li Y, He S, Zhan Y, He A, Gong Y, Ji G, et al. microRNA-183-3p inhibits progression of human prostate cancer by downregulating high-mobility group nucleosome binding domain 5. DNA Cell Biol. 2019;38:840\u20138.","journal-title":"DNA Cell Biol"},{"key":"138_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.200205017","volume":"159","author":"T Cai","year":"2002","unstructured":"Cai T, Nishida K, Hirano T, Khavari PA. Gab1 and SHP-2 promote Ras\/MAPK regulation of epidermal growth and differentiation. J Cell Biol. 2002;159:103\u201312.","journal-title":"J Cell Biol"},{"key":"138_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/jid.2014.326","volume":"135","author":"Z Y-m","year":"2015","unstructured":"Y-m Z, Zhang Z-q, Y-y L, Zhou X, Shi X-h, Jiang Q, et al. Requirement of G\u03b1i1\/3\u2013Gab1 signaling complex for keratinocyte growth factor\u2013induced PI3K\u2013AKT\u2013mTORC1 activation. J Invest Dermatol. 2015;135:181\u201391.","journal-title":"J Invest Dermatol"},{"key":"138_CR27","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/hmg\/ddv001","volume":"24","author":"A Sharma","year":"2015","unstructured":"Sharma A, Menche J, Huang CC, Ort T, Zhou X, Kitsak M, et al. A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. Hum Mol Genet. 2015;24:3005\u201320.","journal-title":"Hum Mol Genet"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-020-00138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-020-00138-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-020-00138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T23:24:53Z","timestamp":1625873093000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-020-00138-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1186\/s41065-020-00138-w","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the Ethics Committee of Affiliated Hospital of North Sichuan Medical College.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the patients signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state that there are no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}